Hypoparathyroidism

D Shoback - New England Journal of Medicine, 2008 - Mass Medical Soc
A 58-year-old man is found on laboratory testing to have a serum calcium level of 6.0 mg per
deciliter (normal range, 8.5 to 10.5), an albumin level of 3.9 g per deciliter, and a …

Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus

AA Khan, CA Koch, S Van Uum… - European Journal of …, 2019 - academic.oup.com
Purpose: To provide practice recommendations for the diagnosis and management of
hypoparathyroidism in adults. Methods: Key questions pertaining to the diagnosis and …

Complications of thalassemia major and their treatment

C Borgna-Pignatti, MR Gamberini - Expert review of hematology, 2011 - Taylor & Francis
The life of patients with thalassemia has improved both in duration and in quality in
industrialized countries. Complications are still common and include heart disease (heart …

Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?

P Evangelidis, TM Venou, B Fani, E Vlachaki… - International Journal of …, 2023 - mdpi.com
Hemoglobinopathies, including β-thalassemia and sickle cell disease (SCD), are common
genetic blood disorders. Endocrine disorders are frequent manifestations of organ damage …

A review of drug-induced hypocalcemia

G Liamis, HJ Milionis, M Elisaf - Journal of bone and mineral metabolism, 2009 - Springer
Hypocalcemia (defined as total serum calcium lower than 8.5 mg/dl or as ionized serum
calcium lower than 4.7 mg/dl) is a relatively common metabolic abnormality observed in …

Bone disease in thalassemia: a molecular and clinical overview

P Wong, PJ Fuller, MT Gillespie, F Milat - Endocrine reviews, 2016 - academic.oup.com
Thalassemia bone disease is a common and severe complication of thalassemia—an
inherited blood disorder due to mutations in the α or β hemoglobin gene. In its more severe …

Effect of enhanced iron chelation therapy on glucose metabolism in patients with β‐thalassaemia major

K Farmaki, N Angelopoulos… - British journal of …, 2006 - Wiley Online Library
Recently introduced chelation regimens that combine deferoxamine (DFO) and deferiprone
have been shown to have greater efficacy in promoting iron excretion than either chelator …

Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease

AD Dede, G Trovas, E Chronopoulos… - Osteoporosis …, 2016 - Springer
Thalassemia-associated osteoporosis constitutes a major complication in patients with
thalassemia. This review presents the existing studies on the treatment of thalassemia …

Endocrinopathies in beta thalassemia: a narrative review

TM Venou, F Barmpageorgopoulou, M Peppa… - Hormones, 2024 - Springer
Beta thalassemia is the most common genetic blood disorder, characterized by reduced
production or complete absence of beta-globin chains. The combination of systematic red …

Osteoporosis syndrome in thalassaemia major: an overview

M Toumba, N Skordis - Journal of osteoporosis, 2010 - Wiley Online Library
Osteoporosis in thalassaemia major (TM) represents a prominent cause of morbidity. The
mechanism of pathogenesis of bone disease (BD) in TM is multifactorial and complicated …